Adult liver transplantation at UCL: update 2002.
The authors present the results of a single centre study of 587 liver transplants performed in 522 adults during the period 1984-2002. Results have improved significantly over time due to better pre-, peri- and post-transplant care. One, five, ten and fifteen year actuarial survivals for the whole patient group are 81.2; 69.8; 58.9 and 51.2%. The high incidence of de novo tumors (12.3%), of cardiovascular diseases (7.5%) and of end-stage renal function (3.6%) should be further incentives to tailor the immunosuppression to the individual patient and to direct the attention of the transplant physician to the long-term quality of life of the liver recipient.
Lerut
J
J
Liver Transplant Program, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, 1200 Brussels, Belgium. Lerut@chir.ucl.ac.be
Matthys
J
J
Lemaire
J
J
Van Thuyne
V
V
Ciccarelli
O
O
Goffette
P
P
Peeters
A
A
Aunac
S
S
Boddeus
M
M
Carlier
M A
MA
Danse
E
E
De Kock
M
M
De Reyck
Ch
Ch
Donataccio
M
M
Geubel
A
A
Gonze
D
D
Goubau
P
P
Latinne
D
D
Laterre
P F
PF
Luts
A
A
Cool
G
G
Otte
J B
JB
Horsmans
Y
Y
Martinez
J
J
Orlando
G
G
Rahier
J
J
Reding
R
R
Reynaert
M
M
Starkel
P
P
Sempoux
Ch
Ch
Talpe
St
S
Van Obbergh
L
L
Veyckemans
F
F
Wallemacq
P
P
Wittebolle
X
X
Roggen
F
F
D000328:Adult; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation; D016019:Survival Analysis; D016896:Treatment Outcome
D007166:Immunosuppressive Agents